Depression risk associated with the use of 5α-reductase inhibitors versus α-blockers: A retrospective cohort study in South Korea

Depression risk associated with the use of 5α-reductase inhibitors versus α-blockers: A retrospective cohort study in South Korea

Show other versions (1)

<h4>Background</h4> One of the most prescribed treatments for benign prostatic hyperplasia (BPH) is 5α-reductase inhibitors (5ARI). Europe experienced recent safety issues involving 5ARI and depression symptoms, with similar findings being seen in Western countries. The South Korea has u...

Full description

Bibliographic Details
Main Authors: Bora Yeon, Ah Young Suh, Eunmi Choi, Bonggi Kim, Eunsun Noh, Soo Youn Chung, Soon Young Han
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926175/?tool=EBI

Similar Items

Similar Items